Avalo Therapeutics Statistics
Total Valuation
AVTX has a market cap or net worth of $1.06 billion. The enterprise value is $663.45 million.
| Market Cap | 1.06B |
| Enterprise Value | 663.45M |
Important Dates
The last earnings date was Thursday, August 6, 2026, before market open.
| Earnings Date | Aug 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
AVTX has 53.63 million shares outstanding. The number of shares has increased by 158.89% in one year.
| Current Share Class | 53.63M |
| Shares Outstanding | 53.63M |
| Shares Change (YoY) | +158.89% |
| Shares Change (QoQ) | +116.85% |
| Owned by Insiders (%) | 1.47% |
| Owned by Institutions (%) | 112.16% |
| Float | 40.15M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 18,025.13 |
| Forward PS | n/a |
| PB Ratio | 2.34 |
| P/TBV Ratio | 2.43 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 11,244.89 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 19.31, with a Debt / Equity ratio of 0.00.
| Current Ratio | 19.31 |
| Quick Ratio | 18.94 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -36.27% and return on invested capital (ROIC) is -517.90%.
| Return on Equity (ROE) | -36.27% |
| Return on Assets (ROA) | -18.50% |
| Return on Invested Capital (ROIC) | -517.90% |
| Return on Capital Employed (ROCE) | -19.45% |
| Weighted Average Cost of Capital (WACC) | 8.58% |
| Revenue Per Employee | $1,788 |
| Profits Per Employee | -$3.04M |
| Employee Count | 33 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, AVTX has paid $170,000 in taxes.
| Income Tax | 170,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +115.08% in the last 52 weeks. The beta is 0.79, so AVTX's price volatility has been lower than the market average.
| Beta (5Y) | 0.79 |
| 52-Week Price Change | +115.08% |
| 50-Day Moving Average | 18.37 |
| 200-Day Moving Average | 16.72 |
| Relative Strength Index (RSI) | 55.30 |
| Average Volume (20 Days) | 755,056 |
Short Selling Information
The latest short interest is 12.95 million, so 24.15% of the outstanding shares have been sold short.
| Short Interest | 12.95M |
| Short Previous Month | 12.68M |
| Short % of Shares Out | 24.15% |
| Short % of Float | 32.25% |
| Short Ratio (days to cover) | 11.72 |
Income Statement
In the last 12 months, AVTX had revenue of $59,000 and -$100.33 million in losses. Loss per share was -$4.18.
| Revenue | 59,000 |
| Gross Profit | -47.89M |
| Operating Income | -91.36M |
| Pretax Income | -100.16M |
| Net Income | -100.33M |
| EBITDA | -91.25M |
| EBIT | -91.36M |
| Loss Per Share | -$4.18 |
Balance Sheet
The company has $400.28 million in cash and $242,000 in debt, with a net cash position of $400.03 million or $7.46 per share.
| Cash & Cash Equivalents | 400.28M |
| Total Debt | 242,000 |
| Net Cash | 400.03M |
| Net Cash Per Share | $7.46 |
| Equity (Book Value) | 448.66M |
| Book Value Per Share | 8.48 |
| Working Capital | 386.80M |
Cash Flow
| Operating Cash Flow | -68.29M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 109,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -68.29M |
| FCF Per Share | -$1.27 |
Margins
| Gross Margin | n/a |
| Operating Margin | -154,847.46% |
| Pretax Margin | -169,767.80% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
AVTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -158.89% |
| Shareholder Yield | -158.89% |
| Earnings Yield | -9.43% |
| FCF Yield | -6.42% |
Analyst Forecast
The average price target for AVTX is $44.15, which is 122.64% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $44.15 |
| Price Target Difference | 122.64% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 15 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on December 29, 2023. It was a reverse split with a ratio of 1:240.
| Last Split Date | Dec 29, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:240 |
Scores
AVTX has an Altman Z-Score of 3.67 and a Piotroski F-Score of 2.
| Altman Z-Score | 3.67 |
| Piotroski F-Score | 2 |